These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1876375

  • 1. Problems encountered with the Bethesda System: the University of Iowa experience.
    Bottles K, Reiter RC, Steiner AL, Zaleski S, Bedrossian CW, Johnson SR.
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):410-4. PubMed ID: 1876375
    [Abstract] [Full Text] [Related]

  • 2. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
    Davey DD, Nielsen ML, Naryshkin S, Robb JA, Cohen T, Kline TS.
    Arch Pathol Lab Med; 1996 May; 120(5):440-4. PubMed ID: 8639046
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
    Islam S, West AM, Saboorian MH, Ashfaq R.
    Cancer; 2004 Apr 25; 102(2):67-73. PubMed ID: 15098249
    [Abstract] [Full Text] [Related]

  • 5. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
    Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF.
    J Reprod Med; 1996 Oct 25; 41(10):719-23. PubMed ID: 9026557
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY, Stanbridge EJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 25; 5(7):549-57. PubMed ID: 8827360
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988.
    Diagn Cytopathol; 1989 Jul 25; 5(3):331-4. PubMed ID: 2791840
    [Abstract] [Full Text] [Related]

  • 10. The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology.
    Sherman ME, Dasgupta A, Schiffman M, Nayar R, Solomon D.
    Cancer; 2007 Feb 25; 111(1):15-25. PubMed ID: 17186503
    [Abstract] [Full Text] [Related]

  • 11. Interlaboratory reproducibility of atypical glandular cells of undetermined significance: a national survey.
    Confortini M, Di Bonito L, Carozzi F, Ghiringhello B, Montanari G, Parisio F, Prandi S, GISCi Working Group for Cervical Cytology.
    Cytopathology; 2006 Dec 25; 17(6):353-60. PubMed ID: 17168918
    [Abstract] [Full Text] [Related]

  • 12. [Applicative aspects of liquid-based cytology in cervical cancer screening].
    Liverani M, De Paola F, Danesi S, Fedriga R, Dalbuoni V, Agnoletti R, Amadori AR, Mirra F, Bonoli W, Saragoni L.
    Pathologica; 2006 Dec 25; 98(6):629-34. PubMed ID: 17285839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The minimally abnormal Papanicolaou smear.
    Brotzman GL, Julian TM.
    Am Fam Physician; 1996 Mar 25; 53(4):1154-62. PubMed ID: 8629563
    [Abstract] [Full Text] [Related]

  • 15. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, Anttila A, Nieminen P, Prendiville W.
    Cytopathology; 2008 Dec 25; 19(6):342-54. PubMed ID: 19040546
    [Abstract] [Full Text] [Related]

  • 16. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears.
    Korn AP, Judson PL, Zaloudek CJ.
    J Reprod Med; 1998 Sep 25; 43(9):774-8. PubMed ID: 9777615
    [Abstract] [Full Text] [Related]

  • 17. Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda System.
    Eddy GL, Ural SH, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT.
    Gynecol Oncol; 1997 Oct 25; 67(1):51-5. PubMed ID: 9345356
    [Abstract] [Full Text] [Related]

  • 18. Subdividing atypical glandular cells of undetermined significance according to the Australian modified Bethesda, system: analysis of outcomes.
    Roberts JM, Thurloe JK, Bowditch RC, Laverty CR.
    Cancer; 2000 Apr 25; 90(2):87-95. PubMed ID: 10794157
    [Abstract] [Full Text] [Related]

  • 19. Atypical glandular cells--an update.
    Cangiarella JF, Chhieng DC.
    Diagn Cytopathol; 2003 Nov 25; 29(5):271-9. PubMed ID: 14595795
    [Abstract] [Full Text] [Related]

  • 20. Intralaboratory quality assurance in cervical/vaginal cytology: evaluation of intercytologist diagnostic reproducibility.
    Cocchi V, Carretti D, Fanti S, Baldazzi P, Casotti MT, Piazzi R, Prosperi L, Morselli-Labate AM.
    Diagn Cytopathol; 1997 Jan 25; 16(1):87-92. PubMed ID: 9034745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.